vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and SOLESENCE, INC. (SLSN). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $12.5M, roughly 1.5× SOLESENCE, INC.). SOLESENCE, INC. runs the higher net margin — 1.3% vs -19.7%, a 21.0% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -0.7%). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 12.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

CURI vs SLSN — Head-to-Head

Bigger by revenue
CURI
CURI
1.5× larger
CURI
$19.2M
$12.5M
SLSN
Growing faster (revenue YoY)
CURI
CURI
+36.5% gap
CURI
35.8%
-0.7%
SLSN
Higher net margin
SLSN
SLSN
21.0% more per $
SLSN
1.3%
-19.7%
CURI
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
12.5%
SLSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
SLSN
SLSN
Revenue
$19.2M
$12.5M
Net Profit
$-3.8M
$163.0K
Gross Margin
27.5%
Operating Margin
-17.6%
1.5%
Net Margin
-19.7%
1.3%
Revenue YoY
35.8%
-0.7%
Net Profit YoY
-34.6%
129.2%
EPS (diluted)
$-0.07
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
SLSN
SLSN
Q4 25
$19.2M
$12.5M
Q3 25
$18.4M
$14.6M
Q2 25
$19.0M
$20.4M
Q1 25
$15.1M
$14.6M
Q4 24
$14.1M
$12.6M
Q3 24
$12.6M
$16.9M
Q2 24
$12.4M
$13.0M
Q1 24
$12.0M
$9.9M
Net Profit
CURI
CURI
SLSN
SLSN
Q4 25
$-3.8M
$163.0K
Q3 25
$-3.7M
$-1.1M
Q2 25
$784.0K
$2.7M
Q1 25
$319.0K
$80.0K
Q4 24
$-2.8M
$-559.0K
Q3 24
$-3.1M
$3.0M
Q2 24
$-2.0M
$856.0K
Q1 24
$-5.0M
$893.0K
Gross Margin
CURI
CURI
SLSN
SLSN
Q4 25
27.5%
Q3 25
23.1%
Q2 25
28.9%
Q1 25
23.1%
Q4 24
22.0%
Q3 24
36.2%
Q2 24
28.7%
Q1 24
36.3%
Operating Margin
CURI
CURI
SLSN
SLSN
Q4 25
-17.6%
1.5%
Q3 25
-24.5%
-5.4%
Q2 25
2.5%
9.4%
Q1 25
0.5%
1.8%
Q4 24
-27.4%
-1.8%
Q3 24
-25.8%
19.0%
Q2 24
-20.6%
8.0%
Q1 24
-30.4%
11.3%
Net Margin
CURI
CURI
SLSN
SLSN
Q4 25
-19.7%
1.3%
Q3 25
-20.4%
-7.7%
Q2 25
4.1%
13.1%
Q1 25
2.1%
0.5%
Q4 24
-19.9%
-4.4%
Q3 24
-24.3%
18.1%
Q2 24
-16.4%
6.6%
Q1 24
-42.0%
9.0%
EPS (diluted)
CURI
CURI
SLSN
SLSN
Q4 25
$-0.07
$0.00
Q3 25
$-0.06
$-0.02
Q2 25
$0.01
$0.04
Q1 25
$0.01
$0.00
Q4 24
$-0.05
$0.00
Q3 24
$-0.06
$0.04
Q2 24
$-0.04
$0.01
Q1 24
$-0.09
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
SLSN
SLSN
Cash + ST InvestmentsLiquidity on hand
$27.3M
$1.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$17.6M
Total Assets
$75.7M
$50.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
SLSN
SLSN
Q4 25
$27.3M
$1.3M
Q3 25
$27.8M
$429.0K
Q2 25
$28.1M
$4.1M
Q1 25
$33.4M
$1.8M
Q4 24
$32.1M
$1.4M
Q3 24
$33.2M
$2.9M
Q2 24
$39.5M
$2.4M
Q1 24
$38.8M
$2.0M
Stockholders' Equity
CURI
CURI
SLSN
SLSN
Q4 25
$41.5M
$17.6M
Q3 25
$47.2M
$17.2M
Q2 25
$49.8M
$18.2M
Q1 25
$58.1M
$15.2M
Q4 24
$57.8M
$14.9M
Q3 24
$62.2M
$15.2M
Q2 24
$64.8M
$11.9M
Q1 24
$67.0M
$5.0M
Total Assets
CURI
CURI
SLSN
SLSN
Q4 25
$75.7M
$50.1M
Q3 25
$74.7M
$54.0M
Q2 25
$78.7M
$60.0M
Q1 25
$85.3M
$57.0M
Q4 24
$86.2M
$50.0M
Q3 24
$87.6M
$48.0M
Q2 24
$90.9M
$40.8M
Q1 24
$94.6M
$38.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
SLSN
SLSN
Operating Cash FlowLast quarter
$4.0M
$1.8M
Free Cash FlowOCF − Capex
$3.9M
FCF MarginFCF / Revenue
20.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
11.16×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
SLSN
SLSN
Q4 25
$4.0M
$1.8M
Q3 25
$4.4M
$-2.5M
Q2 25
$2.8M
$-654.0K
Q1 25
$1.9M
$-7.2M
Q4 24
$3.0M
$2.2M
Q3 24
$2.3M
$4.2M
Q2 24
$2.2M
$-565.0K
Q1 24
$666.0K
$-3.9M
Free Cash Flow
CURI
CURI
SLSN
SLSN
Q4 25
$3.9M
Q3 25
Q2 25
Q1 25
$1.8M
Q4 24
$-404.0K
Q3 24
$2.8M
Q2 24
$-1.0M
Q1 24
$-3.9M
FCF Margin
CURI
CURI
SLSN
SLSN
Q4 25
20.5%
Q3 25
Q2 25
Q1 25
12.2%
Q4 24
-3.2%
Q3 24
16.6%
Q2 24
-8.0%
Q1 24
-39.9%
Capex Intensity
CURI
CURI
SLSN
SLSN
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.5%
Q4 24
0.0%
20.6%
Q3 24
0.0%
8.3%
Q2 24
0.0%
3.7%
Q1 24
0.0%
0.9%
Cash Conversion
CURI
CURI
SLSN
SLSN
Q4 25
11.16×
Q3 25
Q2 25
3.56×
-0.25×
Q1 25
6.03×
-90.26×
Q4 24
Q3 24
1.38×
Q2 24
-0.66×
Q1 24
-4.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons